WallStreetZenWallStreetZen

NASDAQ: DMK
Dmk Pharmaceuticals Corp Stock Ownership - Who owns Dmk Pharmaceuticals?

Insider buying vs selling

Have Dmk Pharmaceuticals Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when DMK insiders and whales buy or sell their stock.

DMK Shareholders

What type of owners hold Dmk Pharmaceuticals Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ahmed Shayan Fazlur Rahman312.96%31,614,954$19.25MInsider
John M. Gregory69.83%7,053,993$4.30MInsider
Richard L. Aloi35.57%3,593,039$2.19MInsider
Dennis J. Phd Carlo19.56%1,976,061$1.20MInsider
Thomas J. Tisch17.78%1,796,585$1.09MInsider
Ebrahim Versi9.06%915,139$557.32kInsider
Eddie Wabern Glover7.34%741,668$451.68kInsider
Thomas Moll3.70%374,110$227.83kInsider
Robert O. Hopkins2.74%277,067$168.73kInsider
David J. Marguglio2.68%270,674$164.84kInsider

1 of 3

DMK vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DMK0.49%99.51%
AGRX0.34%99.66%
LSDI5.33%9.76%Net Buying
UPC0.20%0.00%
SBFM5.09%15.13%

Dmk Pharmaceuticals Stock Ownership FAQ

Who owns Dmk Pharmaceuticals?

Dmk Pharmaceuticals (NASDAQ: DMK) is owned by 2.43% institutional shareholders, 493.48% Dmk Pharmaceuticals insiders, and 0.00% retail investors. Ahmed Shayan Fazlur Rahman is the largest individual Dmk Pharmaceuticals shareholder, owning 31.61M shares representing 312.96% of the company. Ahmed Shayan Fazlur Rahman's Dmk Pharmaceuticals shares are currently valued at $18.65M.

If you're new to stock investing, here's how to buy Dmk Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.